logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-11-25 Kairos Pharma, LTD. Murali Ramachandran
(VP of Research and Development)
P COMMON STOCK A 200 $1.59 - $1.59 $318
2024-11-22 Kairos Pharma, LTD. Samuelson Doug
(Chief Financial Officer)
P COMMON STOCK A 2500 $1.50 - $1.50 $3,750
2024-11-20 Kairos Pharma, LTD. Yu John S
(CEO and Chairman)
P COMMON STOCK A 4000 $1.44 - $1.44 $5,760
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6